|
Controls(187)
|
Sex*
| |
| | |
Male, N(%)
|
157(83.9%)
|
| | |
Female,(N%)
|
30(16.1%)
|
| | |
Mean Age#
|
45.5 ± 5.2
|
|
HNSCC & Dysplastic lesions(147)
|
Sex*
| |
| | |
Male, N(%)
|
110(74.8%)
|
| | |
Female,(N%)
|
37(25.2%)
|
| | |
Mean Age#
|
52 ± 6.4
|
| | |
Lymp Node Positive
|
26(17.7%)
|
| | |
Lymp Node Negative
|
121(82.3%)
|
| | |
Tobacco User
|
103(70%)
|
| | |
Tobacco free
|
44(30%)
|
| | |
Alcohol User
|
13(8.8%)
|
| | |
Alcohol free
|
134(91.2%)
|
|
HNSCC (110)
|
Oral Cavity tumors(85)
|
Buccal Mucosa, N(%)
|
32(29.1%)
|
| | |
Tongue, N(%)
|
13(11.8%)
|
| | |
Cheek, N(%)
|
19(17.3%)
|
| | |
Lip, N(%)
|
3(2.7%)
|
| | |
Tonsil, N(%)
|
4(3.6%)
|
| | |
Palate, N(%)
|
2(1.8%)
|
| | |
Alveolus, N(%)
|
11(10%)
|
| | |
Vocal cord, N(%)
|
1(0.9%)
|
| |
Laryngeal Tumors(12) &
|
Larynx, N(%)
|
12(10.9%)
|
| |
Nasopharyngeal Tumor(3)
|
Nassopharynx, N(%)
|
3(2.7%)
|
| |
Orofacial Tumors(10)
|
Maxilla, N(%)
|
5(4.5%)
|
| | |
Mandible, N(%)
|
5(4.5%)
|
| |
Histopathology(110)
|
StageI
|
15(14%)
|
| | |
StageII
|
30(27%)
|
| | |
StageIII
|
34(31%)
|
| | |
StageIV
|
31(28%)
|
|
Dysplastic lesions (37)
| |
Buccal Mucosa, N(%)
|
37(100%)
|
| |
Histopathology(37)
|
Mild Dysplasia
|
5(13.5%)
|
| | |
Moderate Dysplasia
|
19(51.4%)
|
| | |
Severe Dysplasia
|
13(35.1%)
|
- * Difference in sex distribution: Control vs. HNSCC, P = 0.04,
- # Mean age difference: Control vs. HNSCC, P = 0.01.
